- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- August 2023
- 93 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- August 2023
- 99 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- July 2023
- 105 Pages
Middle East, Africa
From €3280EUR$3,450USD£2,755GBP
- Report
- July 2023
- 119 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- June 2023
- 110 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP
- Report
- May 2023
- 186 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- March 2024
- 101 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Book
- March 2019
- 136 Pages

The Neurotoxins market is a subset of the Neurology field, focusing on the development and use of neurotoxins for medical purposes. Neurotoxins are substances that can disrupt the normal functioning of the nervous system, and can be used to treat a variety of neurological conditions. Neurotoxins can be used to treat conditions such as muscle spasms, chronic pain, and movement disorders. They can also be used to treat certain types of cancer, as well as to reduce the symptoms of multiple sclerosis.
The Neurotoxins market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Allergan, Ipsen, Merz, and Revance Therapeutics. These companies offer a range of neurotoxins, including botulinum toxin, hyaluronic acid, and other injectable treatments. Additionally, some companies specialize in the development of new neurotoxins, such as those derived from venom. Show Less Read more